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Type II diabetes mellitus (T2DM) is a widespread metabolic disorder characterized by
insulin resistance precipitating abnormally high blood glucose levels. While the onset
of T2DM is known to be the consequence of a multifactorial interplay with a strong
genetic component, emerging research has demonstrated the additional role of a variety
of epigenetic mechanisms in the development of this disorder. Heritable epigenetic
modifications, such as DNAmethylation and histone modifications, play a vital role in many
important cellular processes, including pancreatic cellular differentiation and maintenance
of normal β-cell function. Recent studies have found possible epigenetic mechanisms to
explain observed risk factors, such as altered atherogenic lipid profiles, elevated body
mass index (BMI), and impaired glucose tolerance (IGT), for later development of T2DM
in children born to mothers experiencing both famine and hyperglycemic conditions. It
is suggested that these epigenetic influences happen early during gestation and are
less susceptible to the effects of postnatal environmental modification as was previously
thought, highlighting the importance of early preventative measures in minimizing the
global burden of T2DM.
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INTRODUCTION
The worldwide rise in type II diabetes mellitus (T2DM) is a
public health issue that must be addressed. According to the
International Diabetes Federation, there were 366 million peo-
ple living with diabetes in 2011, and this number is expected
to rise to 552 million by 2030 (Whiting et al., 2011). T2DM is
a chronic and largely preventable disease defined by high blood
glucose resulting from insulin resistance and is characterized by
risk factors such as family history of disease, obesity, high blood
pressure, and high low-density lipoprotein (LDL) and low high-
density lipoprotein (HDL) levels (AmericanDiabetes Association,
2013). Recent research has shown that fetal development within a
mother’s uterus is affected by the mother’s nutritional intake and
lifestyle, both of which can greatly increase the risk of the fetus
developing T2DM much later in life. Epigenetics, or the herita-
ble changes in gene expression that occur without changes in the
primary DNA sequence, has recently been proposed as a route
through which this process occurs (Russell, 2010).
The main mechanisms through which epigenetics acts to
affect cell phenotype and biological processes are DNA methyla-
tion and histone modifications (Bramswig and Kaestner, 2012).
DNA methylation involves DNA methyltransferases modifying
cytosines to create 5-methylcytosine, with the majority of this
action occurring in CpG islands found in multiple protein-
coding gene promoter regions throughout the human genome.
Methylation of cytosines in these areas is associated with repres-
sion of transcription (Russell, 2010). This gene silencing occurs
through direction prevention of transcriptional promoter bind-
ing as well as the recruitment of transcriptional repressors
(Bramswig and Kaestner, 2012). Repressors that bind to methy-
lated CpG islands then initiate the cascade that ultimately results
in the second primary mechanism of epigenetic regulation: his-
tone modifications and the recruitment of histone deacetyltrans-
ferases (HDACs) (Russell, 2010).
As Russell notes, there are many specific means by which a
histone is modified, including methylation, phosphorylation, or
ubiquitination at varying locations within the complex. However,
one of the most extensively studied is that of acetylation and
deacetylation of the histone tails, a delicate balance that serves
to alter the charge of the histone core, ultimately determining the
ease by which DNA transcription can occur. For example, HDACs
are capable of deacetylating amino-terminal lysine residues on
histone tails, permitting the positively charged lysine residues
of the histone to bind more tightly to the negatively-charged
DNA wrapped around it. This tighter binding allows for more
compact wrapping around the structural scaffolding provided
by the histones. Genes located within this area of tighter bind-
ing are, therefore, transcriptionally repressed as the transcription
machinery is unable to access the gene promoter (2010).
These epigenetic alterations, of which much is known through
various studies in vitro, have also been shown in vivo to be asso-
ciated with environmental influences, not least of which is the
intrauterine environment and its impact on a developing fetus
(Bramswig and Kaestner, 2012). Here, we focus on this environ-
mental link, its epigenetic impact, and the molecular implications
of those epigenetic alterations as points of further exploration
by researchers and novel therapeutic intervention by clinicians
seeking to proactively care for patients at risk for T2DM.
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PRENATAL NUTRITION AND ITS ROLE IN THE
DEVELOPMENT OF T2DM IN OFFSPRING
A current focus in the field of epigenetics is the exploration of
metabolic changes within the intrauterine environment and their
implication on the development of risk factors associated with
T2DMpostnatally. The impact ofmaternal nutrition on lipid pro-
files, impaired glucose handling, high blood pressure, and obesity,
among other risk factors for T2DM, are areas of interest at this
time. With this in mind, the Dutch famine from 1944 to 1945 and
the great amount of data collected from individuals who felt its
effects firsthand offers a unique study cohort to delve into this
topic, with a very brief shortage of food lasting only 5 months
juxtaposed against a backdrop of adequate nutrition before and
after. Additionally, the short time period over which the starva-
tion conditions were experienced inevitably creates for interesting
study parameters in which pregnant mothers were exposed to
these harsh conditions at different trimesters in their pregnancy
(Roseboom et al., 2000). Meticulous records and census data
spanning several decades reveal the far-reaching impact that pre-
natal diet during different trimesters has on the offspring’s health
in adulthood. Furthermore, what is even more astonishing is the
discovery that these impacts are observed even into subsequent
generations (Hillier et al., 2007; Ding et al., 2012).
PRENATAL EXPOSURE TO FAMINE AND LIPID PROFILES IN
ADULTHOOD
A clear relationship has been found between exposure to famine
in utero and the development of an atherogenic lipid profile as an
adult. An atherogenic lipid profile is defined as high LDL levels
in conjunction with low HDL levels, or having a high LDL:HDL
ratio (Roseboom et al., 2000). High LDL levels are recognized by
the American Diabetes Association as a major risk factor for the
development of T2DM (American Diabetes Association, 2013).
Painter et al. found that fetuses exposed to famine at any point
during gestation had elevated LDL:HDL ratios as adults com-
pared to persons not exposed (2006). Within this group, it seems
that persons exposed to famine early in their mothers’ pregnancy
rather than mid- to late-gestation are at a further increased risk
for developing an atherogenic lipid profile, although women had
a higher atherogenic lipid profile than men (Roseboom et al.,
2000).
Interestingly, a more recent look into the same Dutch famine
data found only women to have significantly increased lipid pro-
files, an assessment of total cholesterol, LDL, and HDL. This
discrepancy may be due to the fact that earlier studies neglected
to look at men and women groups separately in their analyses and
also did not include sibling controls. Taking this into account,
Lumey et al. compared two genetically-similar individuals and
gained a more accurate perspective of the direct effects of famine
on the fetus. Based on these findings, it is thought that prena-
tal exposure to famine may have sex-specific outcomes (Lumey
et al., 2009). They further postulate that these outcomes may be
due to separate controls of metabolic pathways in utero; this view
is supported by Roseboom et al., who suggest that there may
be specific times during gestation when there is a strong poten-
tial to influence glucose and cholesterol metabolism (Roseboom
et al., 2000; Lumey et al., 2009). Regardless of when it occurs
and to whom, it is clear that prenatal exposure to famine dur-
ing gestation increases the risk of developing an atherogenic
lipid profile later in life, possibly through epigenetic mecha-
nisms, thereby increasing the risk for the person developing
T2DM.
PRENATAL EXPOSURE TO FAMINE/OVERFEEDING AND THE RISK OF
OBESITY IN ADULTHOOD
Ravelli et al. found that exposure to famine in the first half of
pregnancy increased the risk of developing obesity as adults, yet
an increased BMI was only found in persons exposed very early
in gestation, mirroring the trend found with lipid profiles. These
results suggest that controlling mechanisms for obesity must be
separate from those influencing BMI (Ravelli et al., 1998). While
further work is needed to determine the reasons why varying
exposures lead to these differences, it is quite apparent that expo-
sure to famine during pregnancy leads to an overall increased
risk for obesity and increased BMI as adults, both of which are
important risk factors for the development of T2DM.
Furthermore, a cohort study carried out on 513,501 women
from 1989 to 2003 found that maternal weight gain throughout
pregnancy increases the birthweight of children independently
of genetic factors (Ludwig and Currie, 2010). Much of this
arises from the physiological response of the fetus to overnu-
trition, with normal maternal insulin resistance associated with
pregnancy becoming exaggerated in obese states and increas-
ing the shunting of vital nutrients to the growing fetus. The
fetus, in turn, secretes its own insulin in response, increasing
glucose uptake, and fat storage, and thus causing the increased
birth weights of babies born under these conditions (Ludwig
and Currie, 2010). This effect on the developing fetus carries
over even into adulthood, presumably through epigenetic changes
pre-natally, with the mother’s fasting hyperglycemia providing
one of the most profound and well-studied associations with
immediate and long-term childhood obesity risk (Hillier et al.,
2007).
The means by which this occurs is further complicated by
the existence of so called endocrine-disrupting chemicals (EDCs)
that have the capacity to influence most if not all aspects of
adipose tissue growth, from undifferentiated stromal cells to
mature adipocytes, a phenomenon that is especially detrimen-
tal to children and young adults who are physiologically in the
midst of a time of intense adipocyte hyperplasia (Janesick and
Blumberg, 2011). As Janesick and Blumberg note, these EDCs,
including a wide range of both natural and man-made sub-
stances such as pharmaceuticals, pesticides, and plasticizers like
bisphenol A, possess the ability to modulate important cellular-
signaling pathways via epigenetic alterations (2011). Whether
through normal physiological responses to extraordinary cir-
cumstances or by exogenous substances interacting with the
fetal epigenome, it is clear that there is much more at stake
here. When it comes to pregnancy, healthcare personnel, moth-
ers, and society at large must be aware that any deviation
from ideal fetal development conditions will have implications
on both immediate maternal and fetal health as well as on
the long-term wellness of the child as he or she moves into
adulthood.
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PRENATAL EXPOSURE TO FAMINE AND RISK OF CORONARY ARTERY
DISEASE IN ADULTHOOD
While coronary artery disease (CAD) itself is not a direct risk
factor for T2DM, CAD is associated with high blood pressure,
which is an identified risk factor for the development of T2DM.
Therefore, it is not uncommon for a person with T2DM to also
suffer from CAD as the two diseases are intimately linked through
this association. As such, the development of CAD offers yet
another glimpse into a individual’s underlying susceptibility to
the development of T2DM. An increased rate of CAD in offspring
was found to be positively related to maternal exposure to famine
while pregnant (Painter et al., 2006). Similar to the trends seen
with lipid profiles and BMI, persons exposed to famine early in
pregnancy were more likely to develop CAD as adults than those
exposed in mid- to late-pregnancy, with a mean age of diagnosis
at 47 years of age for those exposed early during the first trimester
and a mean age of diagnosis at 50 years for those exposed later
in the developmental process. Interestingly, persons exposed in
mid- to late-pregnancy did not have a significantly increased risk
for developing CAD than the control group (Painter et al., 2006).
This has interesting implications on the development of T2DM, as
these findings would indicate that there are molecular events that
occur specifically early in gestation that are highly susceptible to
the state of maternal health and nutrition.
PRENATAL EXPOSURE TO FAMINE AND IMPAIRED GLUCOSE
TOLERANCE IN ADULTHOOD
While exposure to famine early in gestation seems to have the
largest impact on future lipid profiles and the development of
CAD, it was found that mid- to late-exposure to famine in utero
appears to have the largest effect on glucose tolerance (Ravelli
et al., 1998). Adults exposed to famine at any point during ges-
tation had higher rates of IGT compared to controls, but persons
exposed in mid- to late-pregnancy had the highest rates of IGT
or T2DM (Ravelli et al., 1998; Painter et al., 2006). Furthermore,
the persons with the greatest level of glucose intolerance were the
most likely to be obese. It is important to note that IGT was found
in adults of all body types with prenatal exposure, suggesting that
the underlying mechanism for IGT was not secondary to obesity
but, rather, the cause of it (Ravelli et al., 1998).
These results further solidify earlier explorations of a poten-
tial association between events experienced prenatally in varying
intrauterine environments and the significant effects that expo-
sure has on metabolic control systems. Wellen et al. went a step
further to piece together the missing link between the overly-
ing epigenetic imprint evidenced by histone acetylation and the
means by which this epigenetic influence establishes itself in con-
cordance with environmental change. By measuring global his-
tone acetylation levels in various metabolic states, her group was
able to show that ATP-citrate lyase (ACL), a metabolically impor-
tant enzyme critical in the conversion of glucose-derived citrate
into acetyl-CoA, was needed for histone acetylation. Interestingly,
this acetylation coincided with times of plentiful glucose sup-
ply, tipping the balance to favor global histone acetylation over
HDAC-induced deacetylation, allowing for the expression of spe-
cific metabolic genes as well as promote cellular differentiation
into adipocytes (Wellen et al., 2009). As glucose intolerance and
obesity are major hallmarks of T2DM, this insight is promising
for further elucidation of epigenetic influence on future develop-
ment of chronic disease, in general, and T2DM, specifically.
TIMING OF PRENATAL EXPOSURE TO FAMINE/OVERFEEDING AND ITS
EFFECT ON METHYLATION
What has been a source of confusion is the complex timing
by which epigenetic mechanisms exert their influence on DNA
transcription. For example, the specific regulatory action on the
differentially methylated region (DMR) of the insulin-like growth
factor II (IGF2) and H19 promoters early in gestation may have
long-term effects and may not be susceptible to further epigenetic
modification via environmental or age-related stimuli as was pre-
viously thought (Heijmans et al., 2007). In a study comparing
the extent of methylation at specific CpG islands in human ado-
lescent and middle aged twins, it was found that no significant
distinguishing epigenetic marks could be attributed to differences
in age at these particular loci but, instead, revealed an astonish-
ing consistency in the methylation status, once methylated, of the
IGF2 and H19 promoters (Heijmans et al., 2007). These find-
ings challenge other studies that suggested the possibility of global
epigenetic pliancy arising through the influence of environment,
diet, and age (Fraga et al., 2005). A more recent look into the epi-
genetic footprint of DNA taken from a cohort of monozygotic
twins goes one step further by suggesting that DNA promoter
regions with the greatest level of regulatory action retained the
most stable methylation patterns while those loci that were con-
sidered not as important functionally showed a greater level
of variability in epigenetic imprinting (Kaminsky et al., 2009).
With this discovery, epigenetic influence on a global level is now
believed to occur prior to birth with more subtle changes to loci
of lesser significance occurring throughout life (Kaminsky et al.,
2009).
Heijmans et al. argue that both prenatal and postnatal epige-
netic mechanisms offer plausible explanations for the ultimate
expression of genetic information, but it appears that, at least
in the cases of these particular loci, global epigenetic variabil-
ity in methylation elsewhere in the genome as a result of any
number of environmental factors has a more temporal and, thus,
more limited impact on ultimate phenotypic expression when
compared to the effects of stable methylation patterns estab-
lished in the embryo at IGF2 and H19 in response to intrauterine
environment. Therefore, they propose that epigenetic modifica-
tions occurring during embryological development tend to exert a
greater phenotypic influence on the organism and are more stable
in relation to the length of their influence (Heijmans et al., 2007).
Intuitively, such an early alteration to genetic expression in cells
of a developing fetus carries with it enormous implications for the
cells that are to arise after subsequent mitotic events. By changing
the course of an individual cell, especially a stem cell or an early
progenitor, epigenetics can act on a scale that for all intents and
purposes is global and widespread while at the same time possess-
ing the ability to exert a more tissue specific influence if the effect
occurs after the onset of important differentiation events well into
an individual’s life (Kirchner et al., 2013).
Notably, varying methylation patterns at this same IGF2 locus
were also observed in adults exposed in utero to the Dutch
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famine depending upon the timing of their prenatal exposure.
Individuals who were conceived before the German-imposed
famine and, thus, exposed to the associated effects of mal-
nutrition on the mother later in their gestation period had
similar methylation patterns to those who were not exposed
to famine at all. However, those who were conceived in the
midst of the famine saw an ensuing hypomethylation at CpG
islands within this important promoter site and was read-
ily observed even 60 years later at the time data from the
cohort study was originally released (Heijmans et al., 2008).
Although this is not exactly correlative with the hypermethy-
lation observed in offspring born to GDM mothers, the study
suggests a time of critical importance early in embryological
development for epigenetic influence with the potential for last-
ing regulatory action on this specific portion of the human
genome.
The results found from studying the effect of prenatal nutri-
tion on lipid profiles, obesity, and glucose handling have inter-
esting implications for the development of T2DM in adults.
These are well-appreciated risk factors for T2DM, and exposure
to famine during pregnancy was found to increase all of these
risk factors. However, the timing of exposure to famine and the
effect it has, overall, on fetal metabolic development is less clear.
Highest increased rates of atherogenic lipid profiles, obesity, and
CAD were found with early exposure, while highest increased
rates of glucose intolerance and T2DM itself were found in mid-
to late-exposure. Studies conducted after the publishing of the
glucose intolerance results expressed contrasting perspectives and
highlighted that exposure early in gestation, specifically the first
trimester, was most significant for future risk (Heijmans et al.,
2008). In conjunction with other recent studies that have stressed
the importance of early exposure to adverse events in utero, the
emphasis that Ravelli et al. places on the correlation between late-
gestational exposure and increased risk for future development of
IGT and T2DM is questionable (Heijmans et al., 2008; Ding et al.,
2012).
Given the recent findings and discrepancies in current studies
discussed earlier, more work is needed to determine the influ-
ence that timing of gestational exposure to various intrauterine
insults has on future T2DM development. Once this is achieved,
it will be far less difficult to clarify the means by which prena-
tal epigenetic imprinting interplays with the enormous epigenetic
variation induced postnatally by various environmental stimuli
and aging, pharmaceutical intervention, and lifestyle choices such
as exercise (Fraga et al., 2005; Kaminsky et al., 2009; Pinney et al.,
2011; Nitert et al., 2012; Kirchner et al., 2013). Indeed, as others
have noted previously, such an integration must also incorpo-
rate information regarding more conventional regulators of gene
transcription known to play a pivotal role in immediate cellular
response to changing environmental stimuli. This is no small task,
especially considering the vast unknown that the realm of epi-
genetics still poses as well as the substantial ethical obstacles to
studying these alterations in humans, but by delving ever deeper
in this particular field, science will be one step ever closer to
understanding the truemechanisms by which organisms respond,
survive, and thrive in an incredibly complex and dynamic world
(McGraw et al., 2013).
OTHER GENES BELIEVED TO BE IMPLICATED IN THE
DEVELOPMENT OF T2DM
Tobi et al., working off previous studies that had shown
hypomethylation of the IGF2 DMR to be a result of exposure
to famine during gestation, decided to look at the patterns of
15 other possible genes implicated in metabolic and cardiovas-
cular disease in 60 people conceived during the Dutch famine.
Changes in methylation were seen in six of these 15 candidate
genes in people conceived during the famine compared to their
siblings. Hypermethylation was observed in the GNASAS, MEG3,
IL10, ABCA1, and LEP proximal promoters; hypomethylation was
observed in the INSIGF promoter. When compared to individuals
that were exposed later in gestation, methylation changes in IL10,
GNASAS, and INSIGF were found to be time-sensitive. Also, alter-
ation of themethylation status in INSIGF, GNASAS, and LEPwere
sex-specific with methylation at GNASAS and LEP being specific
for men (Tobi et al., 2009). These results support previous find-
ings that exposure to famine has timing- and sex-specific effects
on a developing embryo.
STEM CELLS: UNLOCKING THE EPIGENETIC PATTERN
A recent study by Xie et al. looking into the differentiation of
human embryonic stem cells (hESCs) into pancreatic β cells pro-
poses a strong epigenetic influence involving chromatin remod-
eling Polycomb group (PcG) proteins. PcG-dependent repres-
sion involves a bivalent histone trimethylation of the H3K4 and
H3K27 histones at particular gene loci often encoding impor-
tant developmental regulatory proteins. This repression renders
these genes inaccessible and transcriptionally inactive. However,
when trimethylation at H3K27 is removed and the PcG-mediated
repression of that gene is released, that particular locus is primed
for transcription. Many genes encoding transcription factors nec-
essary for early pancreatic development, including SOX9, PDX1,
PTF1A, HNF6, NK6.1, and NK6.2, have been shown to be regu-
lated in this manner (Xie et al., 2013). This implies a significant
role for epigenetic mechanisms early in the regulation of stem cell
differentiation into pancreatic endocrine cells.
Recently, this epigenetic interaction has been suggested to
exert its effects even earlier, by presenting a likely regulatory
influence on the onset of embryonic genome activation (EGA)
prior to implantation (Vassena et al., 2011). During the first
few cycles of cellular mitosis post-fertilization, the embryo relies
primarily on mRNA and protein inherited from the mother in
order to carry out the rapid division and high metabolic activ-
ity characteristic of this stage of development. These mechanisms
involve an initial translation of maternal mRNA and catabolism
of oocyte-inherited proteins in the two-cell stage before proper
initiation of embryonic is able to occur (Wang and Latham,
2000; Bushati et al., 2008). Interestingly, this pre-EGA transla-
tion of maternal mRNA involves two waves of activity, the first
involving the translation of protein products that persist through-
out this critical stage of development, suggesting that they have
important regulatory roles in the initiation of EGA, while the sec-
ond wave is highlighted by protein breakdown in order to feed
the rapidly developing cells (Vassena et al., 2011). This process
is both dynamic and occurs before any fetal genomic expres-
sion has taken place, with epigenetic-induced polyadenylation of
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maternal mRNA suggested as a possible regulatory mechanism to
help explain the occurrence of these waves of maternal mRNA
translation (Seydoux, 1996; Vassena et al., 2011).
Vassena et al. also found POU5F1, a critical regulator in cel-
lular pluripotency, to be involved in these pre-EGA epigenetic
events. One of the first genes transcribed by the fetal genome,
POU5F1 is expressed even before EGA occurs through a recom-
bination of maternally-inherited mRNA up until the 2-cell stage.
This process is only relieved by the activation of fetal genomic
transcription, which carries out the transcription of this impor-
tant regulator for the remainder of embryonic development. Once
this occurs, other pluripotency genes such as NANOG, SOX2,
KLF4, and ZFP42, begin to be expressed in a sequential manner,
hinting at a hierarchical scheme by which pluripotency is acquired
in a developing human embryo with POU5F1 playing the role of
master regulator which, when properly expressed, paves the way
for the expression of other pluripotency genes (Vassena et al.,
2011). This work deals primarily with discovering additional
avenues, specifically in altering the epigenome of cells already
differentiated, from which to circumvent the ethical obstacles
imposed on research using pluripotent cells. However, this early
epigenetic influence on genomic activation could 1 day prove
to have ramifications not only for somatic cells reprogramming
but for more targeted and preventative epigenetic therapeutic
interventions as well.
Similarly, epigenetics can also influence the developmental
process later in the fetal development timeline, as seen in already-
differentiated β cells. Current exploration by Ding et al. suggests
a relationship between T2DM and the insulin-like growth factor
II IGF2 and H19 fetal liver mRNA (H19) genes, both of which
encode for fundamental proteins involved in normal pancreatic â-
cell function. It was found that under certain conditions, such as
intrauterine hyperglycemia typical to gestational diabetes melli-
tus (GDM), these genes are epigenetically downregulated through
the addition of methyl groups at CpG islands within highly
variable DMRs of their promoter regions (Ding et al., 2012).
The hypermethylation of these imprinted genes IGF2, which is
maternally methylated, and H19, which is paternally methylated,
corresponded to a decrease in the mRNA expression and sub-
sequent protein product translation, a swollen and disordered
endoplasmic reticulum, as well as an increased insulin response
during feeding and decreased fasting insulin levels within pancre-
atic â-cells isolated from mice offspring of GDM mothers when
compared to control offspring (Ding et al., 2012). This provides
strong evidence to a possible embryological epigenetic compo-
nent to future development of insulin desensitivity associated
with T2DM later in life. Furthermore, inhibited IGF2 and H19
gene expression was also observed in the sperm of adult males
of GDM mothers, suggesting that intrauterine environment epi-
genetically impacts not only somatic cells but germ cells as well,
explaining its potential for transgenerational transmission (Ding
et al., 2012).
In essence, a key reason why no current stem cell, albeit embry-
onic, adult, or induced pluripotent stem cells, can generate the
levels of insulin needed to cure diabetes in mice is most likely
due to lack of proper epigenetic regulation as highlighted by the
mechanisms mentioned earlier. Correcting epigenetic regulation
at the stem cell level in vitro could be the answer to proactive treat-
ment, and possibly cure, of Type 1 diabetes mellitus (T1DM) and
T2DM.
PRENATAL EPIGENETIC REGULATION AND ITS LASTING
EFFECT ON EPIGENETIC REGULATION POSTNATALLY
New insights into both a prenatal and postnatal epigenetic influ-
ence on the same gene locus are now being expressed. One study
performed by Park et al. looked at PDX1, which, like IGF2 and
H19, plays an essential role in the regulation of β-cell growth,
function, and production of insulin. Their group discovered that
decreased expression of PDX1 was shown to contribute to the
progression of T2DM in offspring that experienced intrauterine
growth retardation (IUGR) during embryological development.
As a result of limited supply of oxygen and other nutrients in
the intrauterine environment, IUGR fetal islet cell H3 and H4
histones associated with the PDX1 promoter exhibit significant
decreases in acetylation by means of HDAC recruitment (Park
et al., 2008). As noted previously, it is an interaction between a
hyperacetylated H4 in the region of the insulin gene promotor
and PDX1 that allows for glucose-mediated production of insulin
in β-cells. Without this histone hyperacetylation as observed in
low-glucose environments, β-cell metabolic function is impaired
(Ling and Groop, 2009).
This nutritional deficiency alone is enough to cause decreased
levels of PDX1 protein product, but the effect is further com-
pounded with the progression of age postnatally via increased
deacetylation of the core histones H3 and H4 and a decreased
trimethylation on histone 3 lysine 4 (H3K4) along with a sub-
sequent dimethylation on histone 3 lysine 9 (H3K9), both of
which contribute to the inhibition of genetic expression at this
locus (Park et al., 2008). This was thought to be caused by
HDAC inducement of a demethylase-catalyzed demethylation of
H3K4, which is normally methylated and responsible for the
maintenance of an active chromatin state, thereby providing the
opportunity for potential methylation of H3K9 and the switch to
an inactive chromatin state (Park et al., 2008).
As Park et al. suggest, the heightened H3K9 methylation by
histone methyltransferases concurrent with the passing of time
and postnatal exposure to certain environmental factors pro-
motes DNA methylation of CpG islands in the PDX1 promoter,
providing yet another channel for inhibitory regulation as dis-
cussed earlier (2008). Thesemodifications to the histone structure
and alteration of the overall DNA conformation result in increas-
ingly restricted access for the critical activator protein USF-1 to
the promoter, inhibiting PDX1 transcription and, eventually, pro-
voking the glucose homeostatic mismanagement accompanying
β-cell dysfunction that eventually manifests as T2DM (Park et al.,
2008). What is interesting is that recent mice study results from
Pinney et al. indicate that this aberrant epigenetic repression,
one that arises as a survival response to harsh intrauterine con-
ditions experienced in IUGR, can be reversed by a short course
treatment of Exendin-4, a glucagon-like peptide-1 analog. It is
thought that this occurs by negating the effects of decreased phos-
phorylation and activation of USF-1 under IUGR conditions via
activation of a signaling cascade culminating in the phosphoryla-
tion of many important pancreatic beta cell proteins, allowing for
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proper USF-1 binding to the PDX1 promoter region and the sub-
sequent transcription of the all-important PDX1 protein product
(Pinney et al., 2011).
In summary, PDX1 plays a critical role in the development of
the pancreatic β-cell as well as maintaining its proper function.
As Pinney and Simmons point out, if expression of PDX1 is com-
pletely inhibited, either by mutation or regulatory mechanisms
highlighted above, pancreatic agenesis is often the end-result,
offering a possible explanation for the early onset of the T1DM
phenotype. However, if expression is maintained at a minimal
level, normal β-cell mass can be achieved but with concordant
dysfunction in glucose-stimulated insulin secretion, eventually
resulting in T2DM (Pinney and Simmons, 2010).
CONCLUSION
Although it is widely known that genetics and lifestyle have a
profound impact on the development of T2DM, recent research
surrounding epigenetics has shown that exposure of the fetus to
various abnormal intrauterine environmental states like hyper-
glycemia and famine can also increase the risk of developing
T2DM. Since methylation of CpG islands may be heritable, epi-
genetic activity occurring in the developing fetal genome may
result in lasting effects on our metabolic control. These lasting
effects most likely introduce critical factors in the development
of T2DM later in life (Hillier et al., 2007; Park et al., 2008; Ding
et al., 2012). Thus, the influence that epigenetic mechanisms exert
may be immensely important not only as a means by which
FIGURE 1 | Schematic proposing how genetics, environment, and
epigenetics play a role in contributing to the development of type II
diabetes mellitus. While genetics and environment have an impact on the
development of T2DM on their own, new research indicates that in utero
environment may cause specific epigenetic changes to the fetus’s genome
that may cause susceptibility of the development of T2DM of the fetus
later in life. Therefore, epigenetics also has an impact on the development
of T2DM.
environmental factors impact development of T2DM but also in
its role in establishing one’s risk profile for developing T2DM even
before birth (Figure 1).
The nutritional quality and quantity provided to a developing
embryo serves as a strong predictor of the development several
risk factors associated with T2DM postnatally. For example, poor
nutrient supply within the intrauterine environment is linked to
atherogenic lipid profiles, obesity and IGT later in life, all of which
are risk factors for developing T2DM (Ravelli et al., 1998; Painter
et al., 2006; Wellen et al., 2009; Ludwig and Currie, 2010). Many
animal studies have shown that maternal diet causes a perma-
nent change in the methylation of the offspring, with one study
demonstrating that mice born to mothers with GDM display
hypermethylation and epigenetic downregulation of the IGF2 and
H19 genes, which is associated with insulin desensitivity (Ding
et al., 2012). Differential methylation of the IGF2 gene, as well
as other genes associated with T2DM, has been found to occur
in children born to mothers experiencing famine, pointing to
epigenetics as the mechanistic bridge connecting prenatal nutri-
tion and the onset of T2DM later in life (Heijmans et al., 2007,
2008; Kaminsky et al., 2009; Tobi et al., 2009). Clearly, maternal
nutritional profiles and the intrauterine environment the fetus is
FIGURE 2 | Diagram showing the sequence of events between factors
associated with the intrauterine environment and increased risk for
the development of T2DM. This occurs through the initiation of epigenetic
mechanisms that affect genes involving neuroendocrine regulation. Also
illustrated is the potential treatment of T2DM with therapeutics that work
through epigenetic mechanisms.
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exposed to can play a large role in establishing a fetus’ risk profile
for T2DM and, potentially, other diseases later in life (Figure 2).
The epigenetic profile in the development of T2DM is also
being studied primarily in vitro as a potential therapeutic aid in
the treatment and prevention of metabolic disease. In order for
this approach to be fully realized, however, further exploration
should be carried out in vivo along with clinical trials to determine
the efficacy of these molecular interventions to impact patient
overall well-being and health. Regardless, the unfolding discov-
ery of epigenetics as a missing link between one’s environment
and the onset of T2DM is an exciting step forward in our under-
standing of the multi-factorial development of this disease, one
that may, eventually, help reverse the impact of T2DM on global
health.
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